Quick Answer
OmniAb, Inc. reported R&D Expense of $47.75 million for fiscal year 2025.
OmniAb, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $47.75M | -13.3% |
| 2024 | $55.11M | -2.5% |
| 2023 | $56.52M | +16.9% |
| 2022 | $48.36M | +23.3% |
| 2021 | $39.23M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.38M | -22.1% | -4.5% |
| June 30, 2025 | $10.86M | -22.0% | -13.8% |
| March 31, 2025 | $12.60M | -13.4% | -5.4% |
| September 30, 2024 | $13.32M | -4.0% | -4.4% |
| June 30, 2024 | $13.94M | -1.4% | -4.2% |
| March 31, 2024 | $14.55M | +5.8% | +4.9% |
| September 30, 2023 | $13.87M | +5.1% | -1.9% |
| June 30, 2023 | $14.13M | +23.1% | +2.7% |
- OmniAb, Inc. showed a decrease of -13.3% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2025 period, OmniAb, Inc.’s r&d expense has grown by 21.7% (from $39.23 million to $47.75 million).
- The most recent figure is from OmniAb, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: